Abstract
Not available
| Original language | English |
|---|---|
| Pages (from-to) | N/A-N/A |
| Journal | Journal of Antimicrobial Chemotherapy |
| Issue number | n/a |
| DOIs | |
| Publication status | Published - 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Pharmacology
- Microbiology (medical)
- Infectious Diseases
- Pharmacology (medical)
Keywords
- Health Policy
- Infectious Diseases
- Pharmacology (medical)
- antiretroviral therapy
- dolutegravir
- dual therapy
- lamivudine
- switch strategy
Fingerprint
Dive into the research topics of 'Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver